Allarity Therapeutics, Inc. (ALLR) Ownership

NASDAQ: ALLRTop holders, insider trades and short interest.

ALLR ownership summary

as of October 18, 2026
Institutions
8.1%
of shares outstanding
Insiders
0.31%
of shares outstanding
Shares outstanding
15.9M
Float
15.8M
shares available to trade
Short interest
0.75%
119K shares short
Days to cover
0.94
short interest up 6.5% vs prior month
  • Institutions 8.05%
  • Insiders 0.31%
  • Other investors 91.64%

ALLR top institutional holders

20 largest
Allarity Therapeutics, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Renaissance Technologies Corp2.08%332K$296,701+103,425 (+45.3%)June 30, 2026
2Vanguard Capital Management, LLC1.08%172K$153,757—June 30, 2026
3Geode Capital Management, LLC0.97%155K$138,606−35,526 (−18.7%)June 30, 2026
4State Street Corp0.86%138K$123,152—June 30, 2026
5Militia Capital Management, LLC0.62%99K$88,585+98,978 (0.0%)June 30, 2026
6Citadel Advisors Llc0.58%92K$82,114+91,748 (0.0%)June 30, 2026
7Vanguard Fiduciary Trust Co0.47%75K$67,047—June 30, 2026
8HRT FINANCIAL LLC0.23%37K$33,118+37,003 (0.0%)June 30, 2026
9Northern Trust Corp0.23%37K$32,698−11,569 (−24.1%)June 30, 2026
10Jane Street Group LLC0.23%36K$32,239+36,021 (0.0%)June 30, 2026
11Two Sigma Investments LLC0.17%27K$24,605—June 30, 2026
12UBS Group AG0.17%27K$23,797+3,431 (+14.8%)June 30, 2026
13XTX Topco Ltd0.13%21K$18,691−8,083 (−27.9%)June 30, 2026
14Susquehanna International Group, LLP0.11%17K$15,413+17,221 (0.0%)June 30, 2026
15Virtu Financial LLC0.10%15K$13,713+15,322 (0.0%)June 30, 2026
16Tower Research Capital LLC0.02%2,650$2,372+2,650 (0.0%)June 30, 2026
17Caitong International Asset Management Co., Limited.<0.01%22$20+21 (+2,100.0%)June 30, 2026
18FMR Inc<0.01%13$12+13 (0.0%)June 30, 2026
19Danske Bank A/S.0.00%1$1—June 30, 2026
20JONES FINANCIAL COMPANIES LLLP0.00%1$1—June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 406K shares and 3 cut 55K.

ALLR top mutual fund and ETF holders

3 largest
Allarity Therapeutics, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Fidelity Extended Market Index0.52%82K$73,731−443 (−0.5%)August 31, 2026
2Fidelity Total Market Index0.14%22K$19,839—August 31, 2026
3Fidelity Series Total Market Index0.14%22K$19,328—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

ALLR shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns ALLR

Institutional investors own 8.1% of Allarity Therapeutics's shares and insiders 0.31%. The largest holder is Renaissance Technologies Corp with 2.08% of the shares (332K), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 3 reduced their stake in the latest filings. Short interest is 0.75% of the float, or 0.94 days of average trading volume. The share count rose 293,346.9% since 2023.

Related: ALLR analyst forecast, ALLR key metrics. See the ALLR stock overview for the latest quote and news.

ALLR ownership FAQ

Who owns the most Allarity Therapeutics stock?

The largest shareholders of Allarity Therapeutics are Renaissance Technologies Corp (2.08%), Vanguard Capital Management, LLC (1.08%), Geode Capital Management, LLC (0.97%), State Street Corp (0.86%), Militia Capital Management, LLC (0.62%).

What percentage of Allarity Therapeutics is owned by institutions?

Institutions hold 8.1% of Allarity Therapeutics's shares outstanding; insiders hold 0.31%.

Which funds own Allarity Therapeutics?

The largest fund holders of Allarity Therapeutics are Fidelity Extended Market Index (0.52%), Fidelity Total Market Index (0.14%), Fidelity Series Total Market Index (0.14%).

What is Allarity Therapeutics's short interest?

119K shares of Allarity Therapeutics were sold short, 0.75% of the float; at the average daily volume it would take 0.94 days to cover.

How many shares of Allarity Therapeutics are outstanding?

Allarity Therapeutics has 15.9M shares outstanding, of which 15.8M are in the public float.

Biotechnology: ownership